School has started around the country, which for many kids means a tough adjustment back to early wake-ups, sitting still and homework. This is especially difficult ...

Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent the formation of new substance use disorders and alleviate existing addictions, according to findings from a large study of U.S.

GLP-1 drugs like Ozempic, Wegovy, and Zepbound are prescribed for weight loss, diabetes, and blood-sugar management. But as more people use them, patients are reporting a decrease in cravings for ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose. There is new evidence that drugs like Ozempic can reduce ...

Researchers believe that GLP-1 drugs act on reward areas of the brain that are responsible for food cravings, making it possible that they silence cravings for addictive substances. The Conversation — ...

The medication, typically used for weight loss or diabetes treatment, is showing promise curbing cravings for alcohol and ...

Several million people are addicted to methamphetamines and also use tobacco, cannabis, alcohol, benzos, and opioids.

Childhood deaths are significantly higher among children who lose a parent to drug overdose, homicide, or suicide compared to the general child population, a new University of Michigan study found.

For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...